Novo CEO pressed by Senate to cut rates of obesity, diabetic issues medication CEO Lars Fruergaard Jørgensen informed lawmakers the corporation would consider new talks with insurers concerning the listing prices of Wegovy and copyright should they pledge to maintain the medicines on their own formularies. Will not miss tomorrow's https://waylonnjezw.anchor-blog.com/10918415/an-unbiased-view-of-healthcare-news